HEALTH GUIDES
Cosmetic Surgery Cosmetic Dentistry Family Health Health Insurance Laser Eye Surgery Life Insurance Travel HealthMEDICAL A TO Z
Alternative Medicine Blood Disorders Cancer Dental Disorders Diabetes Digestive Disorders Ear & Hearing Disorders Endocrine Disorders Eye Disorders Genetic Disorders Heart Disorders Infectious Diseases Kidney Disorders Lung Disorders Mental Health Neurological Disorders Skin, Bone & Muscle Disorders Sleep DisordersTOPICS/THEMES
Allergies Alternative Health Arthritis Asthma Blood Disorders Bones & Joints Bowel & Abdominal Problems Cancer Chest Problems Child Health Circulation Problems Diabetes Diet & Nutrition Drug Addiction Ear, Nose, & Throat Problems Elderly Health Eye Problems Heart Problems High Blood Pressure Hormone & Endocrine Problems Infections Infertility Liver Problems Medications Men's Health Mental Health Nervous System Personal & Social Issues Pregnancy & Birth Preventive Health Radiology Sexual Health Skin Problems Sports Medicine Surgery Travel Health Urinary & Kidney Problems Vaccination Women's HealthMISCELLANEOUS
Medic8 Search Terms Of Use About Medic8MS Contin® is a time-released formulation of morphine, usually taken every eight hours for chronic pain. It is the brand name for morphine sulfate marketed by Purdue Pharma.
It is available in tablet and liquid formulas in doses of 15mg, 30mg, 60mg, 100mg and 200mg. Due to its strength, it's typically prescribed to cancer patients and victims of severe but non-cognitive-damaging trauma.
Like its relative cousin OxyContin, MS Contin has been the subject of pharmacy robberies. It is considered particularly dangerous to recreational drug users who are unaware that "contin" is a pharmaceutical industry buzzword for "time-release" or "continuous," because such users are likely to crush and insufflate the pills, which contain a time-release mechanism; insufflation delivers the entire dose of the pill at once instead of gradually, as with the time-release mechanism. This leads to a high rate of overdose among such users.
MS Contin is a DEA Schedule II substance in the United States. Alternative formulations made and marketed by other pharmaceutical companies include Ligand's Avinza® and Faulding Laboratories' Kadian®.
Medic8® Medicines
Page last modified: May 2007
DISCLAIMER: This website/guide is provided for general information only and is not a substitute for professional medical advice. We are not responsible or liable for any diagnosis or action made by a user based on the content of this website. We are not liable for the contents of any external websites listed, nor do we endorse any commercial product or service mentioned or advised on any of the sites. Always consult your own doctor if you are in any way concerned about your health.
LEGAL CONDITIONS AND TERMS OF USE ARE APPLICABLE TO ALL USERS OF THIS GUIDE/WEBSITE. ANY USE OF THIS GUIDE CONSTITUTES YOUR AGREEMENT TO THESE TERMS OF USE. REPRODUCTION OF ANY PART OF THIS WEBSITE BY ANY MEANS, INCLUDING ELECTRONIC, IS EXPRESSLY PROHIBITED WITHOUT PRIOR WRITTEN CONSENT.
www.medic8.com
© Medic8 ® All Rights Reserved.
- Medic8 - Health Guide - Mortgage Guide - A to Z - Medical Dictionary - Terms Of Use - Privacy - About -